ecp immunomodulation for cutaneous lymphoma: current & future perspectives
Published 6 years ago • 196 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
0:37
immune checkpoint inhibitors: shaping the future of lymphoma
-
1:15
the diagnosis and management of mds/mpn with neutrophilia (atypical cml)
-
1:28
first-in-human study of iph4102 for relapsed cutaneous t-cell lymphoma
-
3:18
a phase i study of jbh492, an anti-ccr7 antibody-drug conjugate, in lymphoid malignancies
-
6:31
an overview of trials investigating asciminib in the treatment of ph cml
-
6:15
how to manage and report aes associated with bispecific antibody treatment in myeloma
-
11:11
암환자의 nk 면역세포 강화 방법
-
2:09
heart transplantation in attr amyloidosis
-
0:50
insights into the phase ii window-2 trial
-
1:12
the evolving role of allosct in treatment of lymphoma
-
1:31
pegenzileukin for t-cell dysfunction
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
2:32
tools and biomarkers being used for the diagnosis of bpdcn
-
1:21
novel approaches to harnessing the immune system in lymphoma
-
2:15
the role of pet/ct in assessing early treatment response in patients with ndmm
-
3:28
the sympatico trial: ibrutinib plus venetoclax in tp53-mutated mcl
-
1:17
adcs in lymphoma
-
5:21
chemo-free regimens in lymphoma
-
2:11
the t-cell lymphoma project: prospective data collection changing the world
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl